Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BARSON G. J., CRAWFORD N., RAINS A. J., SHARPE S. H., SHREWSBURY J. F. Management of an artery-graft bank; with special reference to sterilisation by beta-propiolactone. Lancet. 1956 Oct 20;271(6947):830–832. [PubMed] [Google Scholar]
- GLENDENNING O. M., ROE F. J. The carcinogenicity of beta-propiolactone for mouseskin. Br J Cancer. 1956 Jun;10(2):357–362. doi: 10.1038/bjc.1956.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
- ORLANS E. S., JONES V. E. beta-Propiolactone as a toxoiding agent. Nature. 1958 Nov 1;182(4644):1216–1217. doi: 10.1038/1821216a0. [DOI] [PubMed] [Google Scholar]
- SMITH H. H., SRB A. M. Induction of mutations with beta-propiolactone. Science. 1951 Nov 9;114(2967):490–492. doi: 10.1126/science.114.2967.490. [DOI] [PubMed] [Google Scholar]
- WALPOLE A. L., ROBERTS D. C., ROSE F. L., HENDRY J. A., HOMER R. F. Cytotoxic agents. IV. The carcinogenic actions of some monofunctional ethyleneimine derivatives. Br J Pharmacol Chemother. 1954 Sep;9(3):306–323. doi: 10.1111/j.1476-5381.1954.tb01686.x. [DOI] [PMC free article] [PubMed] [Google Scholar]